Informa 1H23 Results
H1 2023: Accelerating Growth and Forward Momentum
GROWTH +
MARGIN +
BALANCE SHEET +
DATA ++
SPECIALISATION +
RETURNS +
2023 Half-Year Results
Strong growth in revenue (+53%), adjusted operating profit (+103%) and free cash flow (+63%)
informa
Significant increase in half-year operating margin (+670bpts), ahead of previous full year guidance
Significant balance sheet flexibility, tracking to year-end leverage of 1.3x
Continuing growth in First Party Data, with IIRIS fully consented audience of 20m+
Further Market Specialisation through addition of Tarsus and Winsight in H1 (sub-9x EV/EBITDA) and
acquisitions in specialist Tech Research (Canalys) and Healthcare Tech (HIMSS) (sub-9x EV/EBITDA)
£650m+ total cash returns in 2023, including strong growth in dividends and completion of £1bn
share buyback programme
Full year delivery at the top-end of guidance range for Revenue and Adjusted Operating Profit
All numbers are based on Continuing Operations
1 informa today announced exclusivity to acquire HIMSS Global Health Exhibition/Conference
11View entire presentation